Phytonanoformulations as New Frontier in Effective Management of Diabetes Mellitus Type 2

The chronic metabolic disease known as type 2 diabetes mellitus (T2DM) is typified by β-cell dysfunction, insulin resistance,
and poor glucose metabolism. Despite the availability of pharmacological treatments, many patients experience inadequate
glycemic control and adverse side effects. Recent developments in nanomedicine, especially the application of
phytonanoparticles (PNPs), have demonstrated potential as a cutting-edge strategy for the treatment of type 2 diabetes.
Phytonanoparticles are plant-based nanoparticles with special qualities like low toxicity, biocompatibility, and antioxidant
activity that make them excellent options for treating diabetes. Phytonanoparticles exhibit several mechanisms of action
that can address key aspects of T2DM. Their antioxidant and anti-inflammatory qualities aid in lowering oxidative stress,
which is a major contributor to the etiology of type 2 diabetes. Additionally, PNPs may promote β-cell function, control
glucose homeostasis, and improve insulin sensitivity. Additionally, phytonanoparticles can facilitate the targeted delivery
of therapeutic agents, minimizing side effects and improving drug bioavailability. This review explores the synthesis,
characterization, and therapeutic potential of phytonanoparticles in T2DM treatment. Various plant sources, such as
Curcuma longa (turmeric), Azadirachta indica (neem), and Allium sativum (garlic), have been explored for their ability to
produce nanoparticles with anti-diabetic properties. Furthermore, we discuss the mechanisms through which PNPs exert
their beneficial effects, including modulation of inflammatory pathways, enhancement of insulin signaling, and reduction
of hyperglycemia. Although research on PNPs in T2DM is still in its early stages, the results to date suggest that they hold
significant potential as adjuncts to conventional treatments, offering a safer, more effective therapeutic option for managing
T2DM. Phytonanoparticles represent a promising frontier in diabetes therapy, combining the power of plant-based
compounds with nanotechnology to offer a multi-targeted approach to combat Type 2 diabetes mellitus.